- Home
- GLPG vs YOU Comparison
GLPG vs YOU Comparison
Compare GLPG & YOU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- YOU
- Stock Information
- Founded
- GLPG 1999
- YOU 2010
- Country
- GLPG Belgium
- YOU United States
- Employees
- GLPG N/A
- YOU N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- YOU Computer Software: Prepackaged Software
- Sector
- GLPG Health Care
- YOU Technology
- Exchange
- GLPG Nasdaq
- YOU Nasdaq
- Market Cap
- GLPG 2.1B
- YOU 2.3B
- IPO Year
- GLPG 2005
- YOU 2021
- Fundamental
- Price
- GLPG $31.44
- YOU $36.05
- Analyst Decision
- GLPG Sell
- YOU Buy
- Analyst Count
- GLPG 4
- YOU 5
- Target Price
- GLPG $25.33
- YOU $34.40
- AVG Volume (30 Days)
- GLPG 345.0K
- YOU 1.7M
- Earning Date
- GLPG 07-23-2025
- YOU 08-05-2025
- Dividend Yield
- GLPG N/A
- YOU 2.14%
- EPS Growth
- GLPG N/A
- YOU 105.20
- EPS
- GLPG N/A
- YOU 1.59
- Revenue
- GLPG $323,674,692.00
- YOU $835,529,000.00
- Revenue This Year
- GLPG N/A
- YOU $14.81
- Revenue Next Year
- GLPG N/A
- YOU $10.46
- P/E Ratio
- GLPG N/A
- YOU $22.59
- Revenue Growth
- GLPG 5.43
- YOU 19.85
- 52 Week Low
- GLPG $22.36
- YOU $21.67
- 52 Week High
- GLPG $33.86
- YOU $38.88
- Technical
- Relative Strength Index (RSI)
- GLPG 47.00
- YOU 73.29
- Support Level
- GLPG $31.39
- YOU $33.15
- Resistance Level
- GLPG $32.43
- YOU $36.43
- Average True Range (ATR)
- GLPG 0.77
- YOU 1.05
- MACD
- GLPG -0.22
- YOU 0.24
- Stochastic Oscillator
- GLPG 7.22
- YOU 92.77
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.
About YOU Clear Secure Inc.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.